Ikarian Capital, LLC Iveric Bio, Inc. Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $3.05 Million - $4.02 Million	-163,500 Reduced 43.37%	213,521 $5.19 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $10.4 Million - $14.4 Million	-601,762 Reduced 61.48%	377,021 $8.07 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $8.74 Million - $17.3 Million	929,684 Added 1893.49%	978,783 $17.6 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $16.83 $31,347 - $43,421	2,580 Added 5.55%	49,099 $825,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $2.35 Million - $3.19 Million	-170,000 Reduced 78.52%	46,519 $778,000

Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $1.53 Million - $3.79 Million	216,519 New	216,519 $3.52 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.